Evidence map›Paper›PMID 34489601›Full record

ArticleNature biotechnology2022

Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19.

Jihoon W Lee, Yapeng Su, Priyanka Baloni, Daniel Chen, Ana Jimena Pavlovitch-Bedzyk, Dan Yuan, Venkata R Duvvuri, Rachel H Ng, Jongchan Choi, Jingyi Xie and 14 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 119 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 2 countries.

Jihoon W Lee *Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-6749-5111
Yapeng Su *Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. suyapeng.tju@gmail.com.ORCID http://orcid.org/0000-0002-6305-8467
Priyanka BaloniInstitute for Systems Biology, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-3382-4941
Daniel ChenInstitute for Systems Biology, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-6660-6257
Ana Jimena Pavlovitch-BedzykInstitute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Dan YuanInstitute for Systems Biology, Seattle, WA, USA.
Venkata R DuvvuriInstitute for Systems Biology, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-7356-338X
Rachel H NgInstitute for Systems Biology, Seattle, WA, USA.ORCID http://orcid.org/0000-0003-3692-8524
Jongchan ChoiInstitute for Systems Biology, Seattle, WA, USA.ORCID http://orcid.org/0000-0003-0394-9978
Jingyi XieInstitute for Systems Biology, Seattle, WA, USA.
Rongyu ZhangInstitute for Systems Biology, Seattle, WA, USA.
Kim MurrayInstitute for Systems Biology, Seattle, WA, USA.
Sergey KornilovInstitute for Systems Biology, Seattle, WA, USA.
Brett SmithInstitute for Systems Biology, Seattle, WA, USA.
Andrew T MagisInstitute for Systems Biology, Seattle, WA, USA.
Dave S B HoonSt. John's Cancer Institute at Saint John's Health Center, Santa Monica, CA, USA.ORCID http://orcid.org/0000-0003-1915-3683
Jennifer J HadlockInstitute for Systems Biology, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-6103-7606
Jason D GoldmanSwedish Center for Research and Innovation, Swedish Medical Center, Seattle, WA, USA.
Nathan D PriceInstitute for Systems Biology, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-4157-0267
Raphael GottardoVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-3867-0232
Mark M DavisInstitute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-6868-657X
Leroy HoodInstitute for Systems Biology, Seattle, WA, USA.
Philip D GreenbergProgram in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. pgreen@uw.edu.ORCID http://orcid.org/0000-0003-3812-647X
James R HeathInstitute for Systems Biology, Seattle, WA, USA. jim.heath@isbscience.org.ORCID http://orcid.org/0000-0001-5356-4385
Institute for Systems Biology · USUniversity of Washington · USProvidence College · USCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZAFred Hutch Cancer Center · USHoward Hughes Medical Institute · USSaint John's Health Center · USStanford University · US

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
Systems Biology CoreU19AI128914 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI Margaret Juliana McElrath, KENNETH D STUART · 2017 to 2026
$29.5M
MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
The effects of immune-age on immune-response and the molecular mechanisms which drive itP01AI153559 · NIAID · STANFORD UNIVERSITY · PI SHEN-ORR, SHAI SHLOMO · 2021 to 2025
$17.8M
Site Specific Immunophenotyping Assays of COVID19 Patients to Align with NIAID National StudyR01AI141953 · NIAID · INSTITUTE FOR SYSTEMS BIOLOGY · PI BALIGA, NITIN S · 2019 to 2023
$5.7M
High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases ResearchS10OD028685 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BRADLEY, PHILIP · 2020 to 2020
$2.0M
FHCRC High-Performance Computing ClusterS10OD020069 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KOOPERBERG, CHARLES L · 2015 to 2015
$600k
HHS HHSO100201600031CNIAID NIH HHS P01 AI153559NIAID NIH HHS R01 AI141953NIAID NIH HHS T32 AI007290NIAID NIH HHS U19 AI057229NIAID NIH HHS U19 AI128914NIH HHS S10 OD020069NIH HHS S10 OD028685
6 · The paper itself

Abstract

A better understanding of the metabolic alterations in immune cells during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may elucidate the wide diversity of clinical symptoms experienced by individuals with coronavirus disease 2019 (COVID-19). Here, we report the metabolic changes associated with the peripheral immune response of 198 individuals with COVID-19 through an integrated analysis of plasma metabolite and protein levels as well as single-cell multiomics analyses from serial blood draws collected during the first week after clinical diagnosis. We document the emergence of rare but metabolically dominant T cell subpopulations and find that increasing disease severity correlates with a bifurcation of monocytes into two metabolically distinct subsets. This integrated analysis reveals a robust interplay between plasma metabolites and cell-type-specific metabolic reprogramming networks that is associated with disease severity and could predict survival.

Indexed as

Single-Cell AnalysisCOVID-19HumansMonocytesPrognosisT-Lymphocytes

Identifiers

PMID34489601
PMCPMC9206886
OpenAlexW3196841487

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.